Stockholm-based Karo Pharma has divested Swereco, its hospital supply business unit, to private investment company J2L Holding for SKr150m (US$17.4m). Swereco provides products for rehabilitation, intensive care, diabetes treatment and…
Stockholm-based Karo Pharma has divested Swereco, its hospital supply business unit, to private investment company J2L Holding for SKr150m (US$17.4m). Swereco provides products for rehabilitation, intensive care, diabetes treatment and…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


